Literature DB >> 8610224

Plasma interleukin-7 (IL-7) and IL-8 concentrations in acute rheumatic fever and chronic rheumatic heart disease.

N Kütükçüler1, N Narin.   

Abstract

Interleukin-7 (IL-7) and IL-8 productions in 25 children with acute rheumatic fever (ARF) and in 15 children with chronic rheumatic heart disease (CRHD) and in 15 children with streptococcal pharyngitis (SP), were investigated in order to determine whether they have a role in the pathogenesis of rheumatic fever. Significantly higher IL-8 levels were found in ARF patients in the clinically active period. IL-7 concentrations remained unchanged during different stages of rheumatic fever. The decrease of elevated IL-8 concentrations within 3 months and normal IL-8 concentrations in patients with CRHD and SP indicate an excessive production of IL-8, probably by cellular infiltrates in the joint throughout the active period of rheumatic disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8610224     DOI: 10.3109/03009749509095185

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  3 in total

1.  Carotid intima media thickness and arterial stiffness in children with acute rheumatic fever.

Authors:  Murat Çiftel; Osman Yılmaz; Fırat Kardelen; Abdullah Kocabaş
Journal:  Pediatr Cardiol       Date:  2013-06-15       Impact factor: 1.655

2.  Evaluation of serum ischemia modified albumin levels in acute rheumatic fever before and after therapy.

Authors:  Aysun Toker; Zehra Karatas; Hakan Altın; Sevim Karaarslan; Humeyra Cicekler; Hayrullah Alp
Journal:  Indian J Pediatr       Date:  2013-06-28       Impact factor: 1.967

3.  Pharmacogenomics study on cadherin 2 network with regard to HIV infection and methadone treatment outcome.

Authors:  Hsiang-Wei Kuo; Chia-Lung Shih; Jieh-Hen Tsung; Sheng-Wen Liu; Shih-Kai Chu; Hsin-Chou Yang; Hsiao-Hui Tsou; Zih-Hsiang Wang; Andrew C H Chen; Yu-Li Liu
Journal:  PLoS One       Date:  2017-03-30       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.